Resultados de procura - Marion Subklewe

Limitar resultados
  1. 1
    BiTEs better than CAR T cells

    BiTEs better than CAR T cells por Marion Subklewe

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Chimeric Antigen Receptor T Cells: A Race to Revolutionize Cancer Therapy

    Chimeric Antigen Receptor T Cells: A Race to Revolutionize Cancer Therapy por Marion Subklewe, Michael von Bergwelt‐Baildon, Andreas Humpe

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments

    T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments por Naval Daver, Ahmad S. Alotaibi, Veit Bücklein, Marion Subklewe

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab

    Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab por Thomas Köhnke, Christina Krupka, Johanna Tischer, Thomas Knösel, Marion Subklewe

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    A Monocyte Conditioned Medium Is More Effective Than Defined Cytokines in Mediating the Terminal Maturation of Human Dendritic Cells

    A Monocyte Conditioned Medium Is More Effective Than Defined Cytokines in Mediating the Terminal Maturation of Human Dendritic Cells por Anita Reddy, Mark Sapp, Mary Feldman, Marion Subklewe, Nina Bhardwaj

    Publicado 1997
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Recent developments in immunotherapy of acute myeloid leukemia

    Recent developments in immunotherapy of acute myeloid leukemia por Felix S. Lichtenegger, Christina Krupka, Sascha Haubner, Thomas Köhnke, Marion Subklewe

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    B-Cell-Depleting Immune Therapies as Potential New Treatment Options for Systemic Sclerosis

    B-Cell-Depleting Immune Therapies as Potential New Treatment Options for Systemic Sclerosis por Gerhard Zugmaier, Matthias Klinger, Marion Subklewe, Faraz Zaman, Franco Locatelli

    Publicado 2025
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy

    Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy por Sophia K. Khaldoyanidi, Dirk Nagorsen, Anthony S. Stein, G. J. Ossenkoppele, Marion Subklewe

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    Dendritic Cells Cross-Present Latency Gene Products from Epstein-Barr Virus–Transformed B Cells and Expand Tumor-Reactive Cd8+ Killer T Cells

    Dendritic Cells Cross-Present Latency Gene Products from Epstein-Barr Virus–Transformed B Cells and Expand Tumor-Reactive Cd8+ Killer T Cells por Marion Subklewe, Casper Paludan, Ming L. Tsang, Karsten Mahnke, Ralph M. Steinman, Christian Münz

    Publicado 2001
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    CD86 and IL-12p70 Are Key Players for T Helper 1 Polarization and Natural Killer Cell Activation by Toll-Like Receptor-Induced Dendritic Cells

    CD86 and IL-12p70 Are Key Players for T Helper 1 Polarization and Natural Killer Cell Activation by Toll-Like Receptor-Induced Dendritic Cells por Felix S. Lichtenegger, Katharina Mueller, Bettina Otte, Barbara Beck, Wolfgang Hiddemann, Dolores J. Schendel, Marion Subklewe

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    A Web- and App-Based Connected Care Solution for COVID-19 In- and Outpatient Care: Qualitative Study and Application Development

    A Web- and App-Based Connected Care Solution for COVID-19 In- and Outpatient Care: Qualitative Study and Application Development por Timo Schinköthe, Mariano R. Gabri, Manfred Mitterer, Pedro Gouveia, Volker Heinemann, Nadia Harbeck, Marion Subklewe

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Vaccinia Virus Inhibits the Maturation of Human Dendritic Cells: A Novel Mechanism of Immune Evasion

    Vaccinia Virus Inhibits the Maturation of Human Dendritic Cells: A Novel Mechanism of Immune Evasion por Jose Engelmayer, Marie Larsson, Marion Subklewe, Ann Chahroudi, William I. Cox, Ralph M. Steinman, Nina Bhardwaj

    Publicado 1999
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Mechanisms and strategies for safe chimeric antigen receptor T‐cell activity control

    Mechanisms and strategies for safe chimeric antigen receptor T‐cell activity control por Sophia Stock, Anna‐Kristina Klüver, Luisa Fertig, Vivien D. Menkhoff, Marion Subklewe, Stefan Endres, Sebastian Kobold

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  14. 14
    T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment

    T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment por Frauke M. Schnorfeil, Felix S. Lichtenegger, Katharina Emmerig, Miriam Schlueter, Julia Neitz, Rika Draenert, Wolfgang Hiddemann, Marion Subklewe

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Structures of the human and Drosophila 80S ribosome

    Structures of the human and Drosophila 80S ribosome por Andreas M. Anger, Jean‐Paul Armache, Otto Berninghausen, Michael Habeck, Marion Subklewe, Daniel N. Wilson, Roland Beckmann

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Diagnosis of <scp>CLL</scp> revisited: increased specificity by a modified five‐marker scoring system including <scp>CD</scp>200

    Diagnosis of <scp>CLL</scp> revisited: increased specificity by a modified five‐marker scoring system including <scp>CD</scp>200 por Thomas Köhnke, Veronika K. Wittmann, Veit Bücklein, Felix S. Lichtenegger, Zlatana Pasalic, Wolfgang Hiddemann, Karsten Spiekermann, Marion Subklewe

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    CAR T-cell toxicities: from bedside to bench, how novel toxicities inform laboratory investigations

    CAR T-cell toxicities: from bedside to bench, how novel toxicities inform laboratory investigations por Fabiana Perna, Samir Parekh, Caroline Diorio, Melody Smith, Marion Subklewe, Rakesh Mehta, Frederick L. Locke, Nirali N. Shah

    Publicado 2024
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  18. 18
    Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells

    Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells por Felix S. Lichtenegger, Maurine Rothe, Frauke M. Schnorfeil, Katrin Deiser, Christina Krupka, Christian Augsberger, Miriam Schlüter, Julia Neitz, Marion Subklewe

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Denoising Strategies of Functional Connectivity MRI Data in Lesional and Non-Lesional Brain Diseases

    Denoising Strategies of Functional Connectivity MRI Data in Lesional and Non-Lesional Brain Diseases por Stephan Wunderlich, Cagatay Alici, Saeed Motevallia, Veit M. Stoecklein, Louisa von Baumgarten, Florian Schoeberl, Marion Subklewe, Enrico Schulz, Sophia Stoecklein

    Publicado 2025
    Ligazón do recurso
    Pré-impressão
    Engadir a favoritos
    Gardado en:
  20. 20
    The BiTE (bispecific T‐cell engager) platform: Development and future potential of a targeted immuno‐oncology therapy across tumor types

    The BiTE (bispecific T‐cell engager) platform: Development and future potential of a targeted immuno‐oncology therapy across tumor types por Hermann Einsele, Hossein Borghaei, Robert Z. Orlowski, Marion Subklewe, Gail J. Roboz, Gerhard Zugmaier, Peter Kufer, Karim Iskander, Hagop M. Kantarjian

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: